Home » Topics » Regulatory » Health Canada

Health Canada
RSS

Jublia approved in Canada for the treatment of onychomycosis

Oct. 4, 2013

Bayer receives Canadian approval for riociguat in thromboembolic pulmonary hypertension

Sep. 26, 2013

Health Canada approves Roche's Erivedge for advanced basal cell carcinoma

Aug. 28, 2013

Jetrea approved for symptomatic vitreomacular adhesion in Canada

Aug. 19, 2013

Health Canada approves two GSK drugs for metastatic melanoma

July 25, 2013

Breo Ellipta approved in Canada for chronic obstructive pulmonary disease

July 11, 2013

Canadian acceptance of MycoTool for release testing of Roche product

June 18, 2013

Astellas launches Xtandi in Canada for castration-resistant prostate cancer

June 14, 2013

Aerocrine's Niox Mino device approved in Canada

April 17, 2013

Canadian approval for Hologic's HPV assays

April 9, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 26, 2025.
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Feb. 26, 2025
Roche looks to grow with sequencing by expansion tech
BioWorld MedTech
Roche Holding AG revealed plans to launch its sequencing by expansion technology next year, raising the possibility that rival Illumina Inc. could face a real run...
Clots and metastasis in cancer patients start in the lung
BioWorld MedTech
The lung and thrombosis may play a key role in cancer and metastasis progression, according to a collaborative study led by Cornell University scientists. In the...